Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

GM1 ganglioside treatment of spontaneously hypertensive stroke prone rats.

Hernandez NE, MacDonall JS, Stier CT Jr, Belmonte A, Fernandez R, Karpiak SE.

Exp Neurol. 1994 Mar;126(1):95-100.

PMID:
8157130
2.

Protective effects of delapril, indapamide and their combination chronically administered to stroke-prone spontaneously hypertensive rats fed a high-sodium diet.

Biagini G, Zoli M, Torri C, Boschi S, Vantaggiato G, Ballestri M, Baraldi A, Agnati LF.

Clin Sci (Lond). 1997 Nov;93(5):401-11.

PMID:
9486085
3.
4.

Analysis of circadian blood pressure rhythm and target-organ damage in stroke-prone spontaneously hypertensive rats.

Shimamura T, Nakajima M, Iwasaki T, Hayasaki Y, Yonetani Y, Iwaki K.

J Hypertens. 1999 Feb;17(2):211-20.

PMID:
10067790
5.

Dietary arginine fails to protect against cerebrovascular damage in stroke-prone hypertensive rats.

Stier CT Jr, Sim GJ, Levine S.

Brain Res. 1991 May 24;549(2):354-6.

PMID:
1884230
7.

The lipoxygenase inhibitor phenidone protects against proteinuria and stroke in stroke-prone spontaneously hypertensive rats.

Munsiff AV, Chander PN, Levine S, Stier CT Jr.

Am J Hypertens. 1992 Feb;5(2):56-63.

PMID:
1550666
8.

Prevention of stroke with perindopril treatment in stroke-prone spontaneously hypertensive rats.

Wang H, Delaney KH, Kwiecien JM, Smeda JS, Lee RM.

Clin Invest Med. 1997 Oct;20(5):327-38.

PMID:
9336658
9.

Effects of dietary docosahexaenoic acid on survival time and stroke-related behavior in stroke-prone spontaneously hypertensive rats.

Minami M, Kimura S, Endo T, Hamaue N, Hirafuji M, Monma Y, Togashi H, Yoshioka M, Saito H, Watanabe S, Kobayashi T, Okuyama H.

Gen Pharmacol. 1997 Sep;29(3):401-7.

PMID:
9378247
10.

[Effect of dl-3-n-butylphthalide (NBP) on life span and neurological deficit in SHRsp rats].

Zhang LY, Feng YP.

Yao Xue Xue Bao. 1996;31(1):18-23. Chinese.

PMID:
8762459
12.

Antihypertensive effect of sesamin. III. Protection against development and maintenance of hypertension in stroke-prone spontaneously hypertensive rats.

Matsumura Y, Kita S, Tanida Y, Taguchi Y, Morimoto S, Akimoto K, Tanaka T.

Biol Pharm Bull. 1998 May;21(5):469-73.

PMID:
9635502
13.

Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats.

Stier CT Jr, Adler LA, Levine S, Chander PN.

J Hypertens Suppl. 1993 Apr;11(3):S37-42.

PMID:
8315518
14.
15.

Renal function in stroke-prone rats fed a high-K+ diet.

Smeda JS.

Can J Physiol Pharmacol. 1997 Jul;75(7):796-806.

PMID:
9315346
16.

Differential salt-sensitivity in the pathogenesis of renal damage in SHR and stroke prone SHR.

Griffin KA, Churchill PC, Picken M, Webb RC, Kurtz TW, Bidani AK.

Am J Hypertens. 2001 Apr;14(4 Pt 1):311-20.

PMID:
11336176
17.

Effect of high potassium diets on the vascular and renal prostaglandin system in stroke-prone spontaneously hypertensive rats.

Ishimitsu T, Tobian L, Uehara Y, Sugimoto K, Lange JM.

Prostaglandins Leukot Essent Fatty Acids. 1995 Oct;53(4):255-60.

PMID:
8577778
18.
19.

[Antihypertensive effect of docosahexaenoic acid in stroke-prone spontaneously hypertensive rats].

Kimura S.

Yakugaku Zasshi. 2000 Jul;120(7):607-19. Review. Japanese.

PMID:
10920715
20.

[Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder].

Ueno K, Togashi H, Yoshioka M.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2003 Feb;23(1):47-55. Review. Japanese.

PMID:
12690641

Supplemental Content

Support Center